Guangzhou Bio-Gene Biotechnology Joint-stock Co., Ltd.

Guangzhou Bio-Gene Biotechnology Co., Ltd. was founded in 2011, dedicated to becoming a platform for the translation of biomedical materials and health technologies. The company's main business revolves around biomedical materials, specifically including the industrialization of high-value medical devices in the fields of oral, orthopedic, and wound repair, as well as CDMO services for high-value medical devices.
The company has established complete office, laboratory, and GMP factory facilities, and has set up two platforms: the "Guangdong Provincial Engineering Technology Research Center for Drug Carrier Development" and the "Guangdong Provincial Engineering Technology Research Center for Biomedical Materials and Marine Biomaterials." The supporting equipment is valued at over ten million yuan, meeting the requirements for product development and production. After more than a decade, the company has successfully been recognized as a "High-tech Enterprise," an "Academician Expert Workstation," a "Guangdong Provincial Postdoctoral Innovation Practice Base," a "Guangzhou 'Two Highs, Four News' Enterprise," and a "Guangdong Provincial 'Specialized, Refined, Differentiated, and Innovative' Enterprise." At the same time, the company has applied for over 100 invention patents, and has been authorized for more than 30 invention patents to date. It has also won the "Guangdong Provincial Intellectual Property Demonstration Enterprise," the "Guangdong Provincial Patent Gold Award," and the "China Patent Excellence Award." In addition, the company has undertaken more than 30 national, provincial, municipal, and district-level research projects, including key national R&D projects, Ministry of Science and Technology foreign expert cooperation projects, Guangdong Provincial key R&D projects, and Guangzhou Municipal key R&D projects.
The company has achieved mass production of several core raw materials developed in-house, and based on this, is developing a series of Class II and Class III innovative medical device products covering multiple pipelines such as wound repair, orthopedics, oral, and medical aesthetics. The company adheres to a market-demand-oriented approach, linking production, education, research, and medical practice, establishing an efficient resource integration and collaboration mechanism, continuously improving its R&D capabilities and transformation levels, and consistently providing high-quality medical device products and services to make human life healthier and better!